STOCK TITAN

Hims & Hers Health, Inc. - HIMS STOCK NEWS

Welcome to our dedicated page for Hims & Hers Health news (Ticker: HIMS), a resource for investors and traders seeking the latest updates and insights on Hims & Hers Health stock.

Hims & Hers Health, Inc. (HIMS) is a cutting-edge telehealth company, headquartered in San Francisco, California, that revolutionizes the way people access healthcare. Founded in 2013, the company provides a multi-specialty platform connecting consumers to licensed healthcare professionals, offering a seamless path to high-quality medical care for various conditions.

Hims & Hers Health, Inc. specializes in a broad range of wellness products and services. Their portfolio includes treatments for hair loss, sexual wellness products, skincare lines, and oral care solutions. The company also diversifies its offerings through an exclusive range of men's fashion items including sweaters, jackets, corduroy, sport coats, wool overcoats, leather boots, flannel shirts, caps, and candles. All products are conveniently available for purchase through their online platform.

The telehealth services provided by Hims & Hers are comprehensive, covering mental health, sexual health, dermatology, primary care, and more. This robust platform ensures consumers receive professional medical consultations from the comfort of their homes.

Hims & Hers Health, Inc. continues to innovate and expand its services to meet the evolving needs of its customers. Recent achievements include advancements in their telehealth technology, expanding partnerships with renowned medical professionals, and enhancing their product lines. The company is financially sound and continues to grow, reflecting positive market performance and consumer trust.

For the latest updates, financial reports, and company news, Hims & Hers Health remains a significant player in both the wellness product market and the telehealth industry.

Rhea-AI Summary

Hims & Hers Health, Inc. (NYSE: HIMS) will announce its fourth quarter and fiscal year 2021 financial results on February 22, 2022, at 4:00 PM E.T. A conference call will immediately follow at 5:00 PM E.T.. Investors can join the call by dialing +1 (888) 510-2630 for U.S. participants or +1 (646) 960-0137 for international callers, using conference ID #1704296. A live audio webcast will also be available online, with a replay accessible for 12 months. Hims & Hers provides telehealth services across all 50 states, focusing on primary care, mental health, sexual health, and dermatology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
-
Rhea-AI Summary

Hims & Hers Health, Inc. (NYSE: HIMS) has launched its mobile app, enhancing access to modern healthcare for over 500,000 subscription members. The app offers features such as guided programs, 24/7 concierge support, and a curated member store. CEO Andrew Dudum highlighted this launch as a key step in reshaping healthcare experiences. Users can manage treatments, access medical experts, and engage in community Q&As directly through the app. This initiative aims to provide a supportive, holistic approach to health and wellness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.34%
Tags
none
-
Rhea-AI Summary

Hims & Hers Health has announced the launch of its hair loss solutions in collaboration with Walmart. This partnership will allow customers access to a variety of products like minoxidil solutions and shampoos in select Walmart stores and online. The products cater to a significant market, addressing hair loss experienced by 1 in 3 women and two-thirds of men by age 35. Hims & Hers aims to enhance its reach and accessibility, reinforcing its commitment to providing convenient health and wellness solutions to consumers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
none
Rhea-AI Summary

Hims & Hers Health, Inc. (NYSE: HIMS) has announced key leadership changes to enhance its growth trajectory in the telehealth industry. Yemi Okupe, a finance veteran with experience at PayPal, eBay, and Uber, will assume the role of Chief Financial Officer on January 24, 2022. Dr. Patrick Carroll, the current Chief Medical Officer, is appointed to the Board of Directors. The company's strategic focus remains on transforming healthcare and wellness, reporting a 79% revenue growth to $74.2 million in Q3 2021, and expanding its market presence in underpenetrated sectors valued at $65 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.61%
Tags
management
-
Rhea-AI Summary

Hims & Hers Health (NYSE: HIMS) has launched two new prescription products targeting hair loss in women: Topical Finasteride & Minoxidil Spray and Oral Spironolactone. This development aims to address a common issue affecting 30 million women in the U.S. The topical spray combines clinically proven ingredients for easy application, while the oral pill is designed to slow shedding and promote regrowth. These offerings respond to an increasing demand for effective hair loss treatments, with internet searches for hair loss rising 8% over the past year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.91%
Tags
none
-
Rhea-AI Summary

Hims & Hers Health, Inc. has appointed Jay Spitzer as the new Senior Vice President of Investor Relations, bringing over a decade of experience from Walgreens Boots Alliance. The company reported 79% revenue growth to $74.2 million in Q3 2021, with a 95% increase in subscribers, now totaling 551,000. Additionally, partnerships with major brands such as Amazon and Uber were announced. Hims & Hers is set to launch a new mobile platform aimed at enhancing health services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.54%
Tags
management
Rhea-AI Summary

Hims & Hers Health has launched its largest on-demand delivery partnership with Uber Technologies, allowing customers to order personal care products via the Uber Eats app in 12 major U.S. cities, including Los Angeles and Miami. This initiative is expected to enhance accessibility to various health and wellness products, including sexual wellness and skincare items. The partnership is described as a game-changer by Hims & Hers COO Melissa Baird, aiming for further expansions in the future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
partnership
-
Rhea-AI Summary

Hims & Hers Health has unveiled attractive holiday bundles featuring discounts on popular hair and skin products. Consumers can enjoy up to 30% off original prices, with products like the Hims Hair Gift Set priced at $39.90 and the Hers Hair Gift Set at $44.10. The Hims Skin Gift Set is available for $52.50. Additional offerings include a cologne available at 50% off. This initiative aims to meet customer demand for gifting options during the holiday season.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.74%
Tags
none
-
Rhea-AI Summary

Hims & Hers Health, Inc. (NYSE: HIMS) is expanding its market reach by launching an official store on Amazon. This new initiative aims to enhance product accessibility, offering a range of health and wellness products including supplements and sexual health items. CEO Andrew Dudum stated this move addresses increasing consumer demand and allows the company to connect with digitally savvy customers. Exclusive bundles will also be available, including popular personal care products. This development reflects Hims & Hers' strategy to broaden its customer base and capitalize on retail opportunities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.85%
Tags
none
Rhea-AI Summary

Hims & Hers Health has announced the launch of its new mobile app aimed at providing personalized health services to over 500,000 subscribers. The app will feature curated health programs, 24/7 concierge services, and access to both medical experts and a specially designed Member Store for health products. CEO Andrew Dudum emphasized the app as a pivotal step in reshaping healthcare access, promising to streamline the user experience akin to popular platforms like Spotify and Netflix. The app will be available on both iOS and Android in the coming weeks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.99%
Tags
none

FAQ

What is the current stock price of Hims & Hers Health (HIMS)?

The current stock price of Hims & Hers Health (HIMS) is $26.2 as of December 20, 2024.

What is the market cap of Hims & Hers Health (HIMS)?

The market cap of Hims & Hers Health (HIMS) is approximately 5.8B.

What does Hims & Hers Health, Inc. do?

Hims & Hers Health, Inc. is a telehealth company offering wellness products and connecting consumers to licensed healthcare professionals for various medical conditions.

Where is Hims & Hers Health, Inc. based?

The company is based in San Francisco, California.

When was Hims & Hers Health, Inc. founded?

The company was founded in 2013.

What types of products does Hims & Hers offer?

Hims & Hers offers hair loss prevention medicines, sexual wellness products, skincare products, oral care solutions, as well as men's fashion items like sweaters, jackets, and leather boots.

What medical services are available through Hims & Hers?

The company provides telehealth services covering mental health, sexual health, dermatology, primary care, and more.

How can I purchase products from Hims & Hers?

Products are available for purchase online through their platform.

How is Hims & Hers Health, Inc. performing financially?

Hims & Hers Health, Inc. is financially sound and continues to grow, reflecting positive market performance.

What recent achievements has Hims & Hers Health, Inc. made?

Recent achievements include advancements in telehealth technology, expanding partnerships with medical professionals, and enhancing product lines.

Does Hims & Hers collaborate with healthcare professionals?

Yes, Hims & Hers connects consumers with licensed healthcare professionals for consultations and medical care.

What makes Hims & Hers Health, Inc. unique?

Hims & Hers combines a broad range of wellness products with comprehensive telehealth services, enabling convenient access to high-quality medical care from home.

Hims & Hers Health, Inc.

NYSE:HIMS

HIMS Rankings

HIMS Stock Data

5.76B
184.35M
11.37%
65.88%
18.09%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
SAN FRANCISCO